stockportfolio.pro
West Pharmaceutical Services, Inc. P/E Ratio 2008–2025
West Pharmaceutical Services, Inc. (WST) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth +6.8%/yr over 17 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 40.45 | -17.0% |
| FY 2024 | 48.72 | +9.8% |
| FY 2023 | 44.36 | +47.1% |
| FY 2022 | 30.15 | -43.6% |
| FY 2021 | 53.45 | -12.6% |
| FY 2020 | 61.13 | +32.8% |
| FY 2019 | 46.03 | +31.6% |
| FY 2018 | 34.99 | -27.4% |
| FY 2017 | 48.21 | +12.3% |
| FY 2016 | 42.93 | -3.4% |
| FY 2015 | 44.46 | +53.5% |
| FY 2014 | 28.96 | -1.7% |
| FY 2013 | 29.47 | +32.8% |
| FY 2012 | 22.20 | +37.7% |
| FY 2011 | 16.12 | -18.1% |
| FY 2010 | 19.68 | +19.9% |
| FY 2009 | 16.41 | +24.5% |
| FY 2008 | 13.18 | — |
Source: West Pharmaceutical Services, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for West Pharmaceutical Services, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeWest Pharmaceutical Services, Inc. — frequently asked questions
What is West Pharmaceutical Services, Inc.'s price-to-earnings ratio?
West Pharmaceutical Services, Inc. (WST) reported price-to-earnings ratio of 40.45 for fiscal year 2025, per its SEC filings.
How has West Pharmaceutical Services, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2008 and 2025, WST's price-to-earnings ratio grew at roughly 6.8% per year (compound annual rate), from 13.18 to 40.45.
Where does this data come from?
Figures are computed from West Pharmaceutical Services, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.